StockData
Edwards Lifesciences Corp logo

Edwards Lifesciences Corp (EW) stock

EWNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 10/3060% above fair value
$107.15+1.35 (+1.28%)

Close on Nov 13, 2026Market cap $61.76BP/E 60.5Yield –

Edwards Lifesciences price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Edwards Lifesciences's price to book ratio was 5.7× on Nov 11, 2026, against 4.9× a year earlier. Over the last 5 years it ranged from 4.2× to 14.6×, with a median of 6.2×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20265.7×+0.9
2025Dec 31, 20254.9×+0.3
2024Dec 31, 20244.6×−2.4
2023Dec 29, 20236.9×−0.5
2022Dec 30, 20227.4×−7.2
2021Dec 31, 202114.6×+1.1
2020Dec 31, 202013.5×+0.7
2019Dec 31, 201912.8×+3.2
2018Dec 31, 20189.5×+2.0
2017Dec 29, 20177.5×+0.1
2016Dec 30, 20167.4×+0.4
2015Dec 31, 20157.0×+0.4
2014Dec 31, 20146.7×+1.7
2013Dec 31, 20135.0×−1.8
2012Dec 31, 20126.8×+0.8
2011Dec 30, 20116.0×+3.1
2010Jul 30, 20102.8×−3.1
2009Dec 31, 20095.9×–

More Edwards Lifesciences figures

See a number that looks wrong?